A previous study indicated that the most frequent gene alteration in lung adenocarcinomas in Japanese patients is the EGFR mutation, with an incidence of 38%, while the most frequent gene alteration in Caucasians is KRAS mutation, with an incidence of 30% (19). The gene discussed is EGFR; the disease is lung adenocarcinoma.